Die Behandlung des Mammakarzinoms Therapiekonzept der neunziger Jahre

  • W. Jonat
Part of the AGO Arbeitsgemeinschaft für Gynäkologische Onkologie book series (AGO)

Zusammenfassung

Die Therapie des Mammakarzinoms ist in den letzten Jahren durch 2 Aspekte wesentlich beeinflußt worden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Early breast cancer trialists’ collaborative group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. New Engl J Med 319: 1681–1692, 1988CrossRefGoogle Scholar
  2. 2.
    Henderson I.C.: Adjuvant systemic therapy of early breast cancer and endocrine therapy of metastatic breast cancer. In: Harris J.R., Hellman S., Henderson I.C., Kinne D.W., eds. Breast diseases. Philadelphia: Lippincot J.B., 324–353, 1987Google Scholar
  3. 3.
    Jonat W., Kaufmann M., Abel U.: Chemo- or Endocrine Adjuvant Therapy Alone or Combined in Postmenopausal Patients (GABG Trial 1). In: Senn HJ., Goldhirsch A., Gelber R.D., Osterwalder B. (eds) Recent Results in Cancer Research: Adjuvant Therapy of Primary Breast Cancer 163–169, 1989Google Scholar
  4. 4.
    Kaufmann M., Jonat W., Abel U.: Adjuvant Chemo- and Endocrine Therapy Alone or in Combination in Premenopausal Patients (GABG Trial 1). In: Senn H.J., Goldhirsch A., Gelber R.D., Osterwalder B. (eds) Recent Results in Cancer Research: Adjuvant Therapy of Primary Breast Cancer 118–125, 1989Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • W. Jonat

There are no affiliations available

Personalised recommendations